SHPH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Shuttle Pharmaceuticals Holdings Inc (SHPH) is not a strong buy for a beginner, long-term investor at this time. The company shows weak financial performance, lacks positive trading signals, and has no significant catalysts to drive growth or price appreciation. Holding off on investing until better signals or improvements in financials emerge is recommended.
The technical indicators suggest a bearish trend. The MACD is slightly positive but expanding, while the RSI is neutral at 37.841. The moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading near its pivot level of 0.966. Key resistance levels are at 1.086 and 1.16, while support levels are at 0.845 and 0.771.
NULL identified. The MACD is slightly positive, but this is not a strong enough signal to act upon.
The company recently announced a public offering of 2.24 million shares, which could dilute existing shareholder value. Additionally, the financial performance is weak, with a significant drop in net income (-37.97% YoY) and EPS (-97.35% YoY).
In Q3 2025, the company reported zero revenue growth (0.00% YoY), a significant drop in net income to -$2,347,302 (-37.97% YoY), and a sharp decline in EPS to -1.05 (-97.35% YoY). Gross margin remained at 0, indicating no profitability.
No analyst rating data or price target changes are available for SHPH.
